Dasatinib
NDC 70748-209, Dasatinib, tablet, from Lupin Pharmaceuticals, Inc..
- Product NDC
- 70748-209
- Status
- Listed
- Labeler
- Lupin Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214350
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70748-209 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DASATINIB50 mg/1
Pharmacologic classes
Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70748-209-07 | 70748020907 | 1 BOTTLE in 1 CARTON (70748-209-07) / 60 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f60261dd-b8ea-4511-bed6-ad6d7f4dd828
Use it
Look up 70748-209 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70748-209 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70748-209. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.